ライフサイエンスコーパス: morbidity

1 common practice that can lead to injury and morbidity.

2 the major cause of nonrelapse mortality and morbidity.

3 of stillbirth and infant death and neonatal morbidity.

4 infections are a major source of associated morbidity.

5 leading cause of infant mortality and adult morbidity.

6 women in preterm labor to reduce neurologic morbidity.

7 risk of treatment-related complications and morbidity.

8 rachomatis (Ct) infection causes significant morbidity.

9 ut together represent a substantial cause of morbidity.

10 portion of survivors still have substantial morbidity.

11 ory skin disease that results in significant morbidity.

12 the association of time-varying exposures on morbidity.

13 valve ablation remains a cause of long-term morbidity.

14 tected no increased risk for early childhood morbidity.

15 ion of school aeroallergen exposures to such morbidity.

16 tween ND-E/I, lung function, and respiratory morbidity.

17 ogic cancer that causes significant skeletal morbidity.

18 s mediated through asphyxia-related neonatal morbidity.

19 nvestigate the effect of early MV receipt on morbidity.

20 , and there was no difference in in-hospital morbidity.

21 atory disease with high mortality and severe morbidity.

22 otherapy have no increased risk for surgical morbidity.

23 s often forego to avoid treatment-associated morbidities.

24 n resistance, type 2 diabetes and associated morbidities.

25 oups and in individuals with obesity-related morbidities.

26 There was no difference of surgical morbidity (18.7% vs 25.3%; P = 0.83), rate of reoperatio

27 oss (250 vs 400 mL, P = 0.001), less overall morbidity (22% vs 39%, P = 0.001), shorter High Dependen

28 race/ethnicity), 88 had serious respiratory morbidity, 257 infants had neurosensory impairment, and

29 Primary outcome was postoperative 30-day morbidity, according to Clavien-Dindo classification.

30 ANCE STATEMENT Epilepsy is a common cause of morbidity after traumatic brain injury in early childhoo

31 the effect of an IPM intervention on asthma morbidity among mouse-sensitized and exposed children an

32 Dysanapsis is associated with increased morbidity among obese children with asthma and may partl

33 as an independent predictor of postoperative morbidity among patients undergoing hepato-pancreatic or

34 rker of frailty, and predictor of a range of morbidities and all-cause mortality.

35 ferences and to the impact of psychiatric co-morbidities and medications.

36 approximately 100,000 people suffer serious morbidity and 10,000 people die each year from the conse

37 with both elevated CRP and AGP in WRA.Recent morbidity and abnormal anthropometric status are consist

38 The CCR7-/- mice show a significantly higher morbidity and are more prone to pathogen dissemination a

39 Because these diseases have high levels of morbidity and can be lethal, it is important to understa

40 veloped a new scoring system for calculating morbidity and compared it with CCI.

41 Concern about its associated morbidity and cost has led to a large body of research t

42 e most prevalent infectious diseases causing morbidity and death in >1.5 million patients annually.

43 cal consequences associated with incremental morbidity and death.

44 ers, some of which are characterized by high morbidity and disabilities.

45 tic brain injury (TBI) is a leading cause of morbidity and disability, with a considerable socioecono

46 in severe forms that might cause substantial morbidity and even mortality, particularly when the synd

47 odenectomy (PD), associated with significant morbidity and healthcare-related costs.

48 y aggressive desmoid tumors can cause severe morbidity and loss of function.

49 s the major cause of non-research-associated morbidity and mortality affecting the supply of rhesus m

50 rsus host disease (GVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic c

51 ovascular events represent a major source of morbidity and mortality after liver transplantation and

52 (CVD) complications are important causes of morbidity and mortality after orthotopic liver transplan

53 Increased risks of cardiac morbidity and mortality among childhood cancer survivors

54 cal disease continues to be a major cause of morbidity and mortality among children younger than 5 ye

55 cell disorders, considered a major cause of morbidity and mortality among genetic diseases.

56 Invasive fungal infections cause significant morbidity and mortality among immunocompromised individu

57 ed and is a significant source of congenital morbidity and mortality among newborns.

58 Influenza is an important cause of morbidity and mortality among older adults.

59 In response to increases in pertussis morbidity and mortality among young infants, several cou

60 with remarkable reduction of cardiovascular morbidity and mortality and all-cause death.

61 nt preeclampsia is associated with increased morbidity and mortality and different patterns of LV rem

62 nal human influenza virus continues to cause morbidity and mortality annually, and highly pathogenic

63 easonal influenza viruses cause considerable morbidity and mortality annually, while emerging viruses

64 In an apparent paradox, morbidity and mortality are lower in obese patients unde

65 cially disadvantaged children face increased morbidity and mortality as they age.

66 ning because it is associated with increased morbidity and mortality as well as increased risk of chr

67 ic health measures to prevent and reduce the morbidity and mortality attributable to DHRs.

68 laparoscopic procedures have a lower risk of morbidity and mortality compared with operations requiri

69 IGM) is a primary immunodeficiency with high morbidity and mortality compared with those seen in heal

70 Summary reports from morbidity and mortality conference discussions were link

71 Morbidity and mortality conference is a common education

72 ial pathogens and the associated increase of morbidity and mortality demonstrate the immediate need f

73 rus infection is associated with significant morbidity and mortality due to complications of liver ci

74 e have recently become an important cause of morbidity and mortality due to healthcare-associated inf

75 ease Study 2013 includes estimates of global morbidity and mortality due to skin diseases.

76 ospitalized but less likely to suffer severe morbidity and mortality during the 2009 influenza pandem

77 However, knowledge in DHRs morbidity and mortality epidemiological data is still no

78 utation in humans, DeltaF508, show increased morbidity and mortality following infection with a commo

79 E) are a significant source of perioperative morbidity and mortality following noncardiac surgery.

80 to treat, and patients are at risk for early morbidity and mortality from complications of diabetes.

81 in has the potential to substantially reduce morbidity and mortality from coronary artery disease wor

82 uting to multidrug resistance, and increased morbidity and mortality from diagnostic delays all contr

83 t disease (GVHD) is the predominant cause of morbidity and mortality from GVHD after allogeneic stem

84 ultiple sclerosis (MS) suffer from increased morbidity and mortality from infectious diseases, indepe

85 tion is a critical strategy for reducing the morbidity and mortality from pertussis.

86 y patients with asthma have highest rates of morbidity and mortality from their disease than younger

87 ypanosoma cruzi and is an important cause of morbidity and mortality in areas of Latin America where

88 iated with a profound and severe increase in morbidity and mortality in burn patients during initial

89 Bone metastasis is a prominent cause of morbidity and mortality in cancer.

90 e, genus Phlebovirus) has caused significant morbidity and mortality in China, South Korea, and Japan

91 n-related risk factors are a major source of morbidity and mortality in China, where the expansion of

92 Portal hypertension (PH) is a major cause of morbidity and mortality in chronic liver disease.

93 e pathogenic bacteria that cause significant morbidity and mortality in humans worldwide.

94 hly pathogenic respiratory virus that causes morbidity and mortality in humans.

95 ype 3 (PIV3) infections are a major cause of morbidity and mortality in immunocompromised individuals

96 ed diarrhea are significant global causes of morbidity and mortality in infants.

97 EC) has long remained a significant cause of morbidity and mortality in neonatal intensive care units

98 -associated nephropathy is a major source of morbidity and mortality in patients because of the lack

99 gal infections continue to cause significant morbidity and mortality in patients with compromised imm

100 pies is emerging to be an important cause of morbidity and mortality in patients with current or prio

101 Diabetes mellitus (DM) is a risk factor for morbidity and mortality in patients with heart failure.

102 PA pressure-guided HF management reduces morbidity and mortality in patients with HFrEF on GDMT,

103 study identifies putative factors affecting morbidity and mortality in patients with NS.

104 nsporter 2 inhibitor, reduced cardiovascular morbidity and mortality in patients with type 2 diabetes

105 oviral therapy (ART) substantially decreases morbidity and mortality in people living with HIV.

106 Cancer remains an important cause of morbidity and mortality in people with human immunodefic

107 Acute Chest Syndrome (ACS), a major cause of morbidity and mortality in SCD patients.

108 f cardiac resynchronization therapy (CRT) on morbidity and mortality in selected patients are well kn

109 l bloodstream infection is a common cause of morbidity and mortality in sub-Saharan Africa, yet few f

110 lay in reducing the leading global causes of morbidity and mortality in the growing population of HEI

111 usceptibility to PTB and prematurity-related morbidity and mortality in the offspring.

112 loodstream infections are a leading cause of morbidity and mortality in the United States and are ass

113 nfection and disease are important causes of morbidity and mortality in transplant recipients.

114 Sweden in 2016, critical decisions to reduce morbidity and mortality include rapid selection and dist

115 omplications significantly contribute to the morbidity and mortality of adults with CHD.

116 on now have potential to counteract the high morbidity and mortality of cardiovascular disease.

117 studies, and observational studies that had morbidity and mortality outcomes, were published in Engl

118 occur regularly in Nigeria, leading to high morbidity and mortality rates for children <5 years of a

119 uma (BAT) is an uncommon situation with high morbidity and mortality rates, and delayed small bowel p

120 uated outcomes included all-cause mortality, morbidity and mortality related to stroke, major cardiac

121 the treatment of even the youngest children, morbidity and mortality remain higher with chronic dialy

122 SUMMARY OF BACKGROUND DATA: Morbidity and mortality remain significant after CRS for

123 lts' capacity for adaptation, and increasing morbidity and mortality risk.

124 Cardiovascular morbidity and mortality were hypothesized to be higher a

125 erosclerosis is a leading cause of worldwide morbidity and mortality whose management could benefit f

126 given the increased risk for weight-related morbidity and mortality with a BMI above this threshold.

127 Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence

128 common in adults, accounting for substantial morbidity and mortality worldwide.

129 common vascular disease and a major cause of morbidity and mortality worldwide.

130 sease (ASCVD) is associated with significant morbidity and mortality worldwide.

131 osis (TB) is responsible for enormous global morbidity and mortality, and current treatment regimens

132 Exposure to ambient air pollution increases morbidity and mortality, and is a leading contributor to

133 published risk models for postoperative CVD morbidity and mortality, and it had appropriate calibrat

134 AKI is associated with high morbidity and mortality, and it predisposes to the devel

135 treatment can reduce maternal and perinatal morbidity and mortality, and the well-established accura

136 associated with an increase in postoperative morbidity and mortality, but the appropriate management

137 AMCase-deficient mice exhibit premature morbidity and mortality, concomitant with accumulation o

138 disorders and is associated with substantial morbidity and mortality, including maternal suicide.

139 Given the epidemic of opioid-related morbidity and mortality, it is critical to understand ho

140 ureus often lead to significant increases in morbidity and mortality, particularly when associated wi

141 ognitive and motor development and increased morbidity and mortality.

142 form, is common and contributes to increased morbidity and mortality.

143 tis and emphysema, and is a leading cause of morbidity and mortality.

144 precipitates lung injury and an increase in morbidity and mortality.

145 aban and was associated with high short-term morbidity and mortality.

146 cipated future reductions in tobacco-related morbidity and mortality.

147 ar are at highest risk for pertussis-related morbidity and mortality.

148 cardiac disease represents a major cause of morbidity and mortality.

149 associated with vulnerability to age-related morbidity and mortality.

150 birth (PTB) is the leading cause of neonatal morbidity and mortality.

151 OSA leads to high cardiovascular morbidity and mortality.

152 considered to consolidate gains in averting morbidity and mortality.

153 in the United States and a leading cause of morbidity and mortality.

154 ase have an increased risk of cardiovascular morbidity and mortality.

155 e in almost any tissue and cause significant morbidity and mortality.

156 It is also linked with worse cardiovascular morbidity and mortality.

157 ature and exclusive cause of malaria-related morbidity and mortality.

158 monia accounting for most measles-associated morbidity and mortality.

159 RI) is a major complication that can lead to morbidity and mortality.

160 f this storage limit are at a higher risk of morbidity and mortality.

161 ajor lifestyle changes and carries increased morbidity and mortality.

162 erlapping risk factors and extreme levels of morbidity and mortality.

163 but experience significant treatment-related morbidity and mortality.

164 table blistering disorders with considerable morbidity and mortality.

165 ic women has a significant effect on disease morbidity and mortality.

166 se organisms are associated with significant morbidity and mortality.

167 slipidemia can markedly alter cardiovascular morbidity and mortality.

168 is associated with greater risks for cardiac morbidity and mortality.

169 of the thoracic aorta, are a major cause of morbidity and mortality.

170 lve into severe AP (SAP) causing significant morbidity and mortality.

171 associated infections result in significant morbidity and mortality.

172 loping world and contribute significantly to morbidity and mortality.

173 g HIV replication and markedly reducing AIDS morbidity and mortality.

174 y and childhood cause considerable childhood morbidity and mortality.

175 ly affect more people and further exacerbate morbidity and mortality.

176 control and face the greatest risk of asthma morbidity and mortality.

177 e of falls and of the subsequent increase in morbidity and mortality.

178 trait that contributes to substantial global morbidity and mortality.

179 commonly complicates CKD and associates with morbidity and mortality.

180 f vitamin D with lower risk of breast cancer morbidity and mortality.

181 apeutic development to limit hRSV-associated morbidity and mortality.

182 tment initiation and prevent improvements in morbidity and mortality.

183 se is a challenging problem with substantial morbidity and mortality.

184 stem (CNS) are often acute, with significant morbidity and mortality.

185 F) patients and is associated with increased morbidity and mortality.

186 tem response; they are major contributors to morbidity and mortality.

187 become more prevalent and may contribute to morbidity and mortality.

188 wall secondary to fecal impaction with high morbidity and mortality; especially if complicated with

189 ested to be a biological marker of long-term morbidity and mortality; however, few studies have been

190 reduced ejection fraction (HFrEF) to reduce morbidity and mortality; however, the use of MRAs in com

191 enza virus-infected mice resulted in reduced morbidity and viral burden, improved lung compliance, an

192 ory viruses to wild great apes, causing high morbidity and, occasionally, mortality.

193 Semen quality was associated with long-term morbidity, and a significantly higher risk of hospitaliz

194 are strongly associated with mortality, ICU morbidity, and biochemical evidence of endothelial injur

195 all-cause mortality, multiple markers of ICU morbidity, and endothelial injury.

196 ublic health problem, due to its prevalence, morbidity, and impact on the quality of life.

197 tation, and with no signs of sepsis or other morbidity, and monitored them for 60 days.

198 t impact of iAEs on 30-day mortality, 30-day morbidity, and prolonged (>/=7 days) postoperative LOS,

199 ollment to age 9 months; the mother reported morbidity, and the field assistants examined the childre

200 ifferences in 30/90/180-day mortality, major morbidity, and unplanned readmissions exist among adult

201 the composite outcome of mortality or severe morbidity (area under the receiver operating characteris

202 , including survival bias and major neonatal morbidities arising before exposure to ligation.

203 ome day 1 and correlated with mortality, ICU morbidity as measured by survivor Pediatric Logistic Org

204 e important insights for preventing/reducing morbidity associated with severe malaria in humans.

205 Over the study period, patient age and multi-morbidity at first presentation of heart failure increas

206 pacts of environmental heat on mortality and morbidity at the population scale are well documented, b

207 ; however, it is associated with significant morbidity because of device-related complications and in

208 significant difference was found in serious morbidity between HSHs and LSHs for bariatric or hiatal

209 rtality and complications as well as initial morbidity but also experienced longer-term quality-of-li

210 ated with substantial long-term neurological morbidity, but primarily in those who have epilepsy, neu

211 0.4 million people, being a leading cause of morbidity by infection.

212 trategy, non-mutilating surgery, and minimal-morbidity chemotherapy (in the case of tumour progressio

213 l effect on linear growth and did not reduce morbidity compared to unfortified SQ-LNS.

214 we noted little differences in the levels of morbidity compression by HIV status, PLHIV-especially wo

215 Foley catheter group); and five of neonatal morbidity, comprising birth asphyxia (n=3), septicaemia

216 Perinatal mortality and morbidity continue to be major global health challenges

217 The high burden of morbidity, coupled with a long latency between BMT and t

218 ates of death prior to discharge and serious morbidities decreased among the NICUs in this study.

219 urgery to bone metastasis cause considerable morbidity, decrements in quality of life, and costs to t

220 Risk factors for composite major morbidity did not differ between ODP and MIDP.

221 Overall postoperative 30-day morbidity did not show any difference between the groups

222 sociated with an increased risk for physical morbidity during adulthood.

223 l measures, quality of life, cardiopulmonary morbidity (e.g., hypotension, bradycardia, bronchospasm,

224 therefore potentially help avoid unnecessary morbidity from high-dose corticosteroid therapy and allo

225 1 complication, and 26.9% experienced major morbidity (>/=grade III), mostly related to pulmonary co

226 of preterm birth often present with medical morbidities; however, variation in their long-term educa

227 ssociated with a 40% increase in respiratory morbidity (HR, 1.40 [95% CI, 1.13-1.74]) and a 50% incre

228 1.13-1.74]) and a 50% increase in diarrheal morbidity (HR, 1.50 [95% CI, 1.09-2.06]), after adjustin

229 nary tract infection development and several morbidities in burn patients through alterations in the

230 ne in vulnerable populations reduces malaria morbidity in Africa, but resistance mutations in the par

231 this study was to assess changes in malaria morbidity in an area of Uganda with historically high tr

232 exposure is associated with increased asthma morbidity in children, yet little is known about the con

233 MAO, which is associated with cardiovascular morbidity in chronic kidney disease (CKD).

234 There may be excess morbidity in critically ill selective serotonin reuptake

235 to Determine Impact on Global Mortality and Morbidity in Heart Failure) trial randomly assigned 8399

236 nomic status (SES) is associated with asthma morbidity in observational studies, but the factors unde

237 Acute lung injury (ALI) is a common cause of morbidity in patients after severe injury due to dysregu

238 fluid rates can potentially help to mitigate morbidity in patients undergoing CRS/HIPEC.

239 uptake inhibitor use and 11 studies reported morbidity in patients using these medications at admissi

240 ized by recurrent thrombosis and gestational morbidity in patients with antiphospholipid autoantibodi

241 This study was done to assess visual morbidity in patients with DR at a peripheral tertiary e

242 t Regimens (TENOR I) study demonstrated high morbidity in patients with severe or difficult-to-treat

243 dominant with pain and can lead to long-term morbidity in survivors.

244 receipt was associated with reduced general morbidity in the following months, supporting that early

245 The preponderance of morbidity in treating patients with medulloblastoma is s

246 Main outcome measures included serious morbidity, in-hospital mortality, intensive care unit ad

247 are evidence-based care bundles that reduce morbidity.In this study, we compared protein adequacy as

248 icillin allergy is associated with increased morbidity including length of hospital stay and an incre

249 in predicting 6-month patient mortality and morbidity, including ambulation, toileting, and cognitio

250 ZIKV-susceptible mice resulted in increased morbidity-including fever, viremia, and viral loads in s

251 e predictive ability for serious respiratory morbidity increased from 34 weeks (AOR, 1.8; 95% CI, 0.9

252 and carbamazepine were associated with high morbidity indices.

253 Sociodemographic, injury mortality, and morbidity information were collected for the whole popul

254 This debilitating morbidity is attributed to axon demyelination resulting

255 he rapid non-linear increase in heat-related morbidity is difficult to quantify, hindering the attrib

256 important risk factor for fetal and maternal morbidity, is considered a global health problem, affect

257 ing intraoperative complications, short-term morbidity, long-term morbidity, short-term mortality, an

258 the lack of effect of MMN supplementation on morbidity measures and limited effect on growth.

259 Frailty predicts postoperative mortality and morbidity more than age alone, thus presenting opportuni

260 he HIV pandemic continues to impose enormous morbidity, mortality, and economic burdens across the gl

261 data for all pregnancies and their outcomes, morbidity, mortality, and household practices related to

262 In multivariable analyses, the odds of major morbidity/mortality were similar for early-career (<15 y

263 Serious respiratory morbidity, neurosensory impairment at 18 to 21 months of

264 rses, the patients benefit from avoidance of morbidities of organ transplant.

265 umans is to reduce the magnitude and term of morbidity of acute, community-acquired infections in imm

266 al to spare substantial numbers of women the morbidity of ALND.

267 s has contributed to increased mortality and morbidity of CDI.

268 implantation can reduce the invasiveness and morbidity of conventional MV surgery.

269 iation of sleep apnea with the incidence and morbidity of hypertension, coronary heart disease, arrhy

270 We must enforce explicit consent about the morbidity of innovative, experimental, or high-risk medi

271 A quantitative landscape of morbidity of survivors, however, has not been described.

272 osite outcome of respiratory or neurosensory morbidity or death after discharge.

273 ody skin examination (FBSE) reduces melanoma morbidity or mortality has prompted an "I" rating from t

274 s have not been associated with increases in morbidity or mortality in transgender men receiving CSHT

275 out any detectable change in length-of-stay, morbidity or mortality.

276 interval (CI) 1.52-6.71, P = 0.002], 30-day morbidity (OR = 2.68, 95% CI 1.89-3.81, P < 0.001), and

277 is associated with significant mortality and morbidity post-transplantation.

278 Primary outcomes were measures of morbidity (prevalence or incidence) and mortality (stand

279 sis of the jaw, kidney dysfunction, skeletal morbidity rate (mean number of skeletal-related events p

280 ints included time to first SRE and skeletal morbidity rate (SMR).

281 MODS carries a high mortality and morbidity rate and adversely affects long-term health ou

282 Morbidity rate has become an important outcome measure,

283 The morbidity rate of hypertriglyceridemic acute pancreatiti

284 l outcomes and impact on short and long-term morbidity rates are yet to be determined.

285 Standardized morbidity ratios (SMRs) were estimated by comparing the

286 s factors were used to estimate standardized morbidity ratios for each NICU.

287 is the keystone to reduce both mortality and morbidity related to IDs.

288 mplications, short-term morbidity, long-term morbidity, short-term mortality, and long-term mortality

289 he SUMMIT (Study to Understand Mortality and Morbidity) study.

290 Household visits were made weekly for morbidity surveillance.

291 To investigate long-term morbidity, the French Reference Center for PIDs initiate

292 the United States, and leads to substantial morbidity, though associated mortality is rare.

293 ibility for the contribution that we make to morbidity through our practice in the intensive care uni

294 ure-Assessment of Reduction in Mortality and Morbidity]) to compare the performance of conventional c

295 Co-morbidity was evaluated using electronic health records

296 No differences in the incidence of common morbidities were observed.

297 Postoperative mortality and morbidity were 0.5% and 32.6% respectively.

298 andomized trials have demonstrated increased morbidity with liberal fluid regimens in abdominal surge

299 ibutes significantly to infant mortality and morbidity with lifelong impact.

300 y recognized as major contributors to visual morbidity worldwide.